Cited by 371SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 8 of the 10 references it cites were found in a registry or an index.

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Open access

Zhang, Wenjuan, Davis, Brian D., Chen, Stephanie S., Sincuir Martinez, Jorge M., Plummer, Jasmine T., Vail, Eric·2021·JAMA

DOI 10.1001/jama.2021.1612PMC PMC7879386

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

This research describes findings of sequencing and phylogenetic analyses of SARS-CoV-2 isolates from symptomatic patients cared for at Cedar-Sinai Medical Center in November-December 2020 during a regional surge in cases and hospitalizations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2021.1612

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178
Genetic Variants of SARS-CoV-2—What Do They Mean?
Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604
Emergence of a new SARS-CoV-2 variant in the UK
Tang, J. W.-T., Tambyah, P. A., & Hui, D. S. C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.024 · Cited by 273
Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic
Zhang, W., Govindavari, J. P., Davis, B. D., Chen, S. S., Kim, J. T., Song, J., Lopategui, J. R., Plummer, J., & Vail, E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.24191 · Cited by 36
Self-citation
S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the USPreprint
Washington, N. L., White, S. J., Barrett, K. M. S., Cirulli, E. T., Bolze, A., & Lu, J. T. (2020) · medRxiv · doi:10.1101/2020.12.24.20248814 · Cited by 35

Show all 10 references

Sorted by citations

Items 201–300 of 369

Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs
Tan, E., Frew, E., Cooper, J., Humphrey, J., Holden, M. T. G., Mand, A. R., Li, J., Anderson, S., Bi, M., Hatler, J. M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11071190 · Cited by 11
Detection of SARS-CoV-2 in Wastewater: Community Variability, Temporal Dynamics, and Genotype Diversity
Song, Z., Reinke, R., Hoxsey, M., Jackson, J., Krikorian, E., Melitas, N., Rosso, D., & Jiang, S. C. (2021) · ACS ES&T Water · doi:10.1021/acsestwater.1c00119 · Cited by 11
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study
Boshier, F. A. T., Venturini, C., Stirrup, O., Guerra‐Assunção, J. A., Alcolea-Medina, A., Becket, A. H., Byott, M., Charalampous, T., Filipe, A. D. S., Frampton, D., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.09.022 · Cited by 11
SARS-CoV-2 surface and air contamination in an acute healthcare setting during the first and second pandemic waves
Otter, J. A., Zhou, J., Price, J. R., Reeves, L., Zhu, N., Randell, P. A., Sriskandan, S., Barclay, W., & Holmes, A. H. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2022.11.005 · Cited by 11
A SARS-CoV-2: Companion Animal Transmission and Variants Classification
Pandit, R., & Matthews, Q. L. (2023) · Pathogens · doi:10.3390/pathogens12060775 · Cited by 11
Spike2CGR: an efficient method for spike sequence classification using chaos game representation
Murad, T., Ali, S., Khan, I., & Patterson, M. (2023) · Machine Learning · doi:10.1007/s10994-023-06371-4 · Cited by 10
Investigation of SARS-CoV-2 Epsilon Variant and Hospitalization Status by Genomic Surveillance in a Single Large Health System During the 2020-2021 Winter Surge in Southern California
Yang, S., Hemarajata, P., Hilt, E. E., Price, T. K., Garner, O. B., & Green, N. M. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab203 · Cited by 10
The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival
Patro, L. P. P., Sathyaseelan, C., Uttamrao, P. P., & Rathinavelan, T. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.054 · Cited by 9
Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy
Malshe, N. S., Patnaik, S., Lalwani, S. K., Suryawanshi, P. B., Kulkarni, R., Mhaske, S. T., Mishra, A. C., & Arankalle, V. A. (2021) · Infection · doi:10.1007/s15010-021-01650-5 · Cited by 10
Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India
Singh, J., Malhotra, A. G., Biswas, D., Shankar, P., Lokhande, L., Yadav, A. K., Raghuvanshi, A., Kale, D., Nema, S., Saigal, S., et al. (2021) · Genes · doi:10.3390/genes12111803 · Cited by 10
REGEN-COV protects against viral escape in preclinical and human studiesPreprint
Copin, R., Baum, A., Wloga, E. H., Pascal, K. E., Giordano, S., Fulton, B. O., Zhou, A., Negron, N., Lanza, K., Chan, N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.10.434834 · Cited by 10
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential
Lam, B. K., Kung, Y. J., Lin, J. W., Tseng, S.-H., Tsai, Y. C., He, L., Castiglione, G. M., Egbert, E. R., Duh, E. J., Bloch, E. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109838 · Cited by 9
The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil
Bittar, C., Possebon, F. S., Ullmann, L. S., Geraldini, D. B., da Costa, V. G., de Almeida, L. G. P., Sanches, P. R. D. S., Nascimento-Júnior, N. M., Cilli, E. M., Banho, C. Á., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.745310 · Cited by 10
Low‐frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled‐edged sword
Magalis, B. R., Mavian, C. N., Tagliamonte, M. S., Rich, S. N., Cash, M. N., Riva, A., Loeb, J. C., Norris, M. H., Amador, D. M., Zhang, Y., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27726 · Cited by 9
Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh
Sayeed, M. A., Ferdous, J., Saha, O., Islam, S., Choudhury, S. D., Abedin, J., Hassan, M. M., & Islam, A. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080197 · Cited by 10
Vaccine development and technology for SARS‐CoV‐2: Current insight
Cattel, L., Giordano, S., Traina, S., Lupia, T., Corcione, S., Angelone, L., Valle, G. L., Rosa, F. G. D., & Cattel, F. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27425 · Cited by 7
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model
Kalnin, K. V., Plitnik, T., Kishko, M., Huang, D., Raillard, A., Piolat, J., Anosova, N. G., Tibbitts, T. J., DiNapoli, J. M., Karve, S., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.01.021 · Cited by 10
The surveillance of spike protein for patients with COVID‐19 detected in Hong Kong in 2020
Mak, G. C. K., Lau, A. W. L., Chan, A. M. Y., Lam, E. T. K., Chan, R. C. W., & Tsang, D. N. C. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27063 · Cited by 8
Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak
Oliveira, M. D. M., Schemberger, M. O., Suzukawa, A. A., Riediger, I. N., Debur, M. D. C., Becker, G., Resende, P. C., Gräf, T., Balsanelli, E., Baura, V. A., et al. (2021) · Virology Journal · doi:10.1186/s12985-021-01690-1 · Cited by 8
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
de Souza, M. O., Madan, B., Teng, I., Huang, A., Liu, L., Fahad, A. S., Acevedo, S. N. L., Pan, X., Sastry, M., Gutiérrez-González, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977064 · Cited by 7
A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding Onwards
Mukherjee, S., & Ray, S. K. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220401101818 · Cited by 9
Omicron variant receptor-binding domain phylogenetics and molecular dynamics
Kandeel, M. K., & El‐Deeb, W. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105633 · Cited by 8
Effects of COVID-19 on Population, Economic Growth, Logistics Performance, and Quality Management in Africa: Grey Relational Analysis
Zineb, A., Zineb, F., Ismael, E. O., & Ikram, M. (2022) · International Journal of Grey Systems · doi:10.52812/ijgs.56 · Cited by 8
Pathogenesis of COVID19 and the applications of US FDA-approved repurposed antiviral drugs to combat SARS-CoV-2 in Saudi Arabia: A recent update by review of literature
Hershan, A. A. (2024) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2024.104023 · Cited by 7
Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories
Buchan, B. W., & Yao, J. D. C. (2021) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2021.05.004 · Cited by 7
The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic
Izadmehr, S., Lundon, D., Mohamed, N., Katims, A., Patel, V. G., Eilender, B. M., Mehrazin, R., Badani, K. K., Sfakianos, J. P., Tsao, C., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.734963 · Cited by 7
Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India
Shrivastava, S., Mhaske, S. T., Modak, M. S., Virkar, R., Pisal, S. S., Mishra, A. C., & Arankalle, V. A. (2022) · Archives of Virology · doi:10.1007/s00705-021-05320-7 · Cited by 7
Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida
Magalis, B. R., Rich, S. N., Tagliamonte, M. S., Mavian, C. N., Cash, M. N., Riva, A., Marini, S., Amador, D. M., Zhang, Y., Shapiro, J., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac197 · Cited by 7
Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study
Gunawardana, M., Webster, S., Rivera, S., Cortez, J. M., Breslin, J., Pinales, C., Buser, C., Ibarrondo, F. J., Yang, O. O., Bobardt, M. D., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00195-4 · Cited by 9
Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization
Wang, J., Zhang, Y., Liu, C., Zha, W., Dong, S., Wang, Y., Jiang, Y., Xing, H., & Li, X. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00860 · Cited by 7
Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials
Blanco, O. R., Dorta, D., Hernández, C. A., Abreu, D., Domínguez, A. G., Luna, Y., Valdivia, O., Pérez-Bernal, M., Tamayo, C., Lemos, G., et al. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.113195 · Cited by 8
An expanded RT-PCR melting temperature coding assay to rapidly identify all known SARS-CoV-2 variants and sub-variants of concern
Banada, P. P., Green, R., Streck, D. L., Kurvathi, R., Reiss, R., Banik, S., Daivaa, N., Montalvan, I., Jones, R., Marras, S. A. E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48647-8 · Cited by 7
COVID-19: The Vaccine Race Continues
Burgess, L. H., Castelein, C., Rubio, A. G., & Cooper, M. K. (2021) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1269 · Cited by 5
Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
Hofman, P. M., Bordone, O., Chamorey, E., Benzaquen, J., Schiappa, R., Lespinet‐Fabre, V., Lantéri, E., Brest, P., Mograbi, B., Maniel, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.730577 · Cited by 7
In silico investigations of heparin binding to SARS‐CoV‐2 variants with a focus at the RBD/ACE2 interface
Ali, N., Khan, R., Alasmari, A. F., & Kumar, V. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.02.012 · Cited by 6
Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools
Yadav, D., Agarwal, S., Pancham, P., Jindal, D., Agarwal, V., Dubey, P. K., Jha, S. K., Mani, S., Rachana, R., Dey, A., et al. (2022) · Immuno · doi:10.3390/immuno2020022 · Cited by 7
Mutations of the SARS-CoV-2 Spike Glycoprotein Detected in Cats and Their Effect on Its Structure and Function
Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.875123 · Cited by 6
Genomic epidemiology and emergence of SARS-CoV-2 variants of concern in the United Arab Emirates
AlSafar, H. S., Albreiki, M. S., Mousa, M., Azman, S. K., Vurivi, H., Waasia, F. Z., Ruta, D., Hosani, F. I. A., Mazrouei, S. A., Abuyadek, R. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16967-w · Cited by 6
Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations
Wu, J., Zhang, H., & Zhang, J. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp04349a · Cited by 6
Efficient Classification of SARS-CoV-2 Spike Sequences Using Federated Learning
Chourasia, P., Murad, T., Tayebi, Z., Ali, S., Khan, I., & Patterson, M. (2024) · Communications in computer and information science · doi:10.1007/978-3-031-63616-5_6 · Cited by 8
Can proteomics-based approaches further help COVID-19 prevention and therapy?
Kumar, V. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1924684 · Cited by 6
Rapid detection of SARS-CoV-2 variants by molecular-clamping technology-based RT-qPCR
Shen, S., Fu, A. Y., Jamba, M., Li, J. Z., Cui, Z., Pastor, L., Cataldi, D., Sun, Q., Pathakamuri, J. A., Kuebler, D., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04248-23 · Cited by 6
Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong
Tsang, A. K. L., Mak, G. C. K., Cheng, P. K. C., Yip, P. C. W., Ng, K. H. L., Lam, E. T. K., Chan, R. C. W., & Tsang, D. N. C. (2021) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2021.100029 · Cited by 5
Diversidad genómica en SARS-CoV-2: Mutaciones y variantes
Aguilar–Gamboa, F. R., Suclupe-Campos, D. O., Vega-Fernández, J. A., & Silva-Díaz, H. (2021) · Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo · doi:10.35434/rcmhnaaa.2021.144.1465 · Cited by 5
SARS-CoV-2 Variants Impact on Key Signaling Pathways Metamorphoses into Severity
Misra, G., Hora, S., Ginwal, S., Singh, N. K., & Anvikar, A. R. (2023) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2023220261 · Cited by 5
Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread
Ajmera, H., Lakhawat, S. S., Malik, N., Kumar, A., Bhatti, J. S., Kumar, V., Gogoi, H., Jaswal, S. K., Chandel, S., & Sharma, P. K. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037274719231212044235 · Cited by 5
Challenges for Vaccinologists in the First Half of the Twenty-First Century
Thomas, S., Abraham, A., Callaghan, P. J., & Rappuoli, R. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_1 · Cited by 5
Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing
Brett, T. S., & Rohani, P. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac159 · Cited by 5
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study
Kamal, S. M., Naghib, M. M., Daadour, M., Alsuliman, M. N., Alanazi, Z. A., Basalem, A., Alaskar, A. M., & Saed, K. (2023) · Viruses · doi:10.3390/v15020326 · Cited by 5
Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C
Abe, K., Shimura, T., Takenouchi, T., Iwasaki, Y. W., Ishizu, H., Uwamino, Y., Uno, S., Gotoh, J., Tachikawa, N., Takeuchi, Y., et al. (2021) · The Keio Journal of Medicine · doi:10.2302/kjm.2021-0005-oa · Cited by 5
COVID‐19 vaccination in pediatric solid organ transplant recipients—Current state and future directions
L’Huillier, A. G., Ardura, M. I., Chaudhuri, A., Danziger‐Isakov, L. A., Dulek, D. E., Green, M., Michaels, M. G., Posfay-Barbe, K. M., Vásquez, L., & Benden, C. (2021) · Pediatric Transplantation · doi:10.1111/petr.14031 · Cited by 5
Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India
Sarkar, R., Saha, R., Mallick, P., Sharma, R. P., Kaur, A., Dutta, S., & Chawla‐Sarkar, M. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.11.020 · Cited by 6
Role of N501Y Mutation in SARS-CoV-2 Spike Protein StructurePreprint
Roy, U. (2021) · Preprints.org · doi:10.20944/preprints202106.0238.v1 · Cited by 4
ChAdOx1 nCoV-19, BNT162b2 and CoronaVac Vaccines Do Not Induce as Strong Neutralising Antibodies with Broad Variant Protection as Infection and Suggest Vaccines that Induce Broader Sterilising Immunity are Essential to Stop the Pandemic
Chua, J. X., Durrant, L. G., Chok, Y. L., & Lai, O. M. (2022) · iScience · doi:10.1016/j.isci.2022.105379 · Cited by 4
Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
Tuli, H. S., Sak, K., Aggarwal, P., Iqubal, A., Upadhaya, S. K., Kaur, J., Kaur, G., & Aggarwal, D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.763687 · Cited by 4
Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System
Ku, J. H., Levin, M. J., Luo, Y., Florea, A., Lin, I.-C., Tian, Y., & Tseng, H. F. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac236 · Cited by 4
Applications of nanotechnology in the fight against coronavirus disease 2019
Sayad, R., Abdelsabour, H. A., Farhat, S. M., Omer, N. G., Ahmed, M., Elsayh, K. I., Ibrahim, I. H., Algammal, A. M., Al-Kadmy, I. M. S., Batiha, G. E., et al. (2023) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000335 · Cited by 4
Response to mutation and variants of the SARS-CoV-2 gene
Parwanto, E. (2021) · Universa Medicina · doi:10.18051/univmed.2021.v40.77-78 · Cited by 4
Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea
Park, A. K., Rhee, J. E., Kim, I., Kim, H. M., Lee, H., Kim, J., Lee, C. Y., Lee, N., Woo, S., Lee, J., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27499 · Cited by 3
US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell Response
Plummer, J., Contreras, D. A., Zhang, W., Binek, A., Zhang, R., Dezem, F. S., Chen, S. S., Davis, B. D., Martínez, J., Stotland, A. B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac295 · Cited by 3
Self-citation
SARS-CoV-2 Variants in Rhode Island; May 2022 Update.
Singh, M., Novitsky, V., Carpenter‐Azevedo, K., Howison, M., Huard, R. C., King, E., & Kantor, R. (2022) · PubMed · Cited by 4
Rapid, widespread, and preferential increase of SARS-CoV-2 B.1.1.7 variant in Houston, TX, revealed by 8,857 genome sequencesPreprint
Musser, J. M., Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Davis, J. J., & Gollihar, J. (2021) · medRxiv · doi:10.1101/2021.03.16.21253753 · Cited by 4
SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environmentsPreprint
Magalis, B. R., Mavian, C. N., Tagliamonte, M. S., Rich, S. N., Cash, M. N., Riva, A., Loeb, J. C., Norris, M. H., Amador, D. M., Zhang, Y., et al. (2021) · medRxiv · doi:10.1101/2021.05.19.21257237 · Cited by 4
Geographical and temporal distribution of SARS-CoV-2 globally: An attempt to correlate case fatality rate with the circulating dominant SARS-CoV-2 cladesPreprint
Sarkar, R., Chawla‐Sarkar, M., Majumdar, S., Lo, M., & Chattopadhyay, S. (2021) · medRxiv · doi:10.1101/2021.05.25.21257434 · Cited by 4
Emergence of a new SARS-CoV-2 variant from GR clade with a novel S glycoprotein mutation V1230L in West Bengal, IndiaPreprint
Sarkar, R., Saha, R., Mallick, P., Sharma, R. P., Kaur, A., Dutta, S., & Chawla‐Sarkar, M. (2021) · medRxiv · doi:10.1101/2021.05.24.21257705 · Cited by 4
Impact of New Variants on SAR-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein InteractionsPreprint
Cheng, M. H., Krieger, J., Xiang, Y., Kaynak, B., Shi, Y., Arditi, M., & Bahar, İ. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3907841 · Cited by 4
Potential Therapeutic Role of Mesenchymal-Derived Stem Cells as an Alternative Therapy to Combat COVID-19 through Cytokines Storm
Upadhyay, T. K., Trivedi, R., Khan, F., Pandey, P., Sharangi, A. B., Goel, H., Saeed, M., Park, M. N., & Kim, B. (2022) · Cells · doi:10.3390/cells11172686 · Cited by 3
The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations
Cao, B., Wang, X.-X., Yin, W., Gao, Z., & Xia, B.-Q. (2024) · mBio · doi:10.1128/mbio.03187-23 · Cited by 3
Experimental Identification of Immuno- dominant B-cell Epitopes from SARS-CoV-2
Soler, L. F., Daguer, J., Barluenga, S., & Winssinger, N. (2021) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2021.276 · Cited by 3
Genetic Variants of SARS-CoV-2: What Do We Know So Far?
Jamil, S. M., Shafazand, S., Pasnick, S., Carlos, W. G., Maves, R. C., & Cruz, C. S. D. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2021c5 · Cited by 3
SARS-COV2 VARIANTS AND VACCINES MRNA SPIKES FIBONACCI NUMERICAL UA/CG METASTRUCTURES
Perez, J. C. (2021) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v9.i6.2021.4040 · Cited by 4
THE INDIA MUTATIONS AND B.1.617 DELTA VARIANTS: IS THERE A GLOBAL "STRATEGY" FOR MUTATIONS AND EVOLUTION OF VARIANTS OF THE SARS-COV2 GENOME?
Perez, J. C. (2021) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v9.i6.2021.4039 · Cited by 3
A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
Capoferri, A. A., Shao, W., Spindler, J., Coffin, J. M., Rausch, J. W., & Kearney, M. F. (2022) · Viruses · doi:10.3390/v14010104 · Cited by 3
Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variantsPreprint
Ge, A., Rioux, M. L., & Kelvin, A. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.25.437035 · Cited by 3
Optimized Post-Vaccination Strategies and Preventative Measures for SARS-CoV-2Preprint
Pettit, R. W., Peng, B., Yu, P. L., Matos, P. G., Greninger, A. L., McCashin, J., & Amos, C. I. (2021) · medRxiv · doi:10.1101/2021.09.17.21263723 · Cited by 3
A zebrafish model of COVID-19-associated cytokine storm syndrome reveals differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concernPreprint
Tyrkalska, S. D., Martínez‐López, A., Arroyo, A. B., Martínez-Morcillo, F. J., Candel, S., García‐Moreno, D., Mesa-del-Castillo, P., Cayuela, M. L., & Mulero, V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.05.471277 · Cited by 3
Functional implications of hexameric dynamics in SARS ‐ CoV ‐2 Nsp15
Sonowal, M., Ketawala, G. K., Nagaratnam, N., Logeswaran, D., Basu, S., de Sanctis, D., Orlans, J., Rose, S. L., Jernigan, R. J., Hu, H., et al. (2025) · Protein Science · doi:10.1002/pro.70115 · Cited by 2
Omicron Subvariants Infection Kinetics and Nirmatrelvir Efficacy in Transgenic K18-hACE2 Mice
Sharma, V., Dolgov, E., Tillery, T., Romero, C. M., Rojas-Triana, A., Guzmán, D. M. V., Goldgirsh, K., Rasheed, R., González-Jiménez, I., Álvarez, N., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199509 · Cited by 2
SARS-CoV-2 Variants: Impact of Spike Mutations on Vaccine and Therapeutic Strategies
Raman, R., Patel, K. J., & Ranjan, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_7 · Cited by 4
Ligation‐based assay for variant typing without sequencing: Application to SARS‐CoV‐2 variants of concern
Nelson, D. J., Shilts, M. H., Pakala, S., Das, S. R., Schmitz, J. E., & Haselton, F. R. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13083 · Cited by 2
Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
Ilié, M., Benzaquen, J., Hofman, V., Long-Mira, É., Lassalle, S., Boutros, J., Bontoux, C., Lespinet‐Fabre, V., Bordone, O., Tanga, V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043478 · Cited by 2
Epidemiological state, patient’s characteristics, and COVID-19 vaccination levels in Algeria
Khennouchi, N. C. E. H., Meradi, L., Hacini, R., Saighi, R. A., & Yahiaoui, M. (2023) · South Florida Journal of Health · doi:10.46981/sfjhv4n1-018 · Cited by 2
Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies
Nawaz, S., Janiad, S., Fatima, A., Saleem, M., Fatima, U., & Ali, A. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265271109231129112515 · Cited by 2
Overview of diagnostic tools and nano-based therapy of SARS-CoV-2 infection
Bhattacharjee, B., Rynjah, D., Ahmed, A. B., Newar, A., Sengupta, S., Chakrabarty, S., Sahu, R. K., & Khan, J. (2024) · Chemical Papers · doi:10.1007/s11696-023-03271-8 · Cited by 2
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19
Tokhanbigli, S., Ghaleh, S. S., Rahimian, K., Mahmanzar, M., Bayat, S., Ahangarzadeh, S., Moradi, B., Mahmanzar, R., Wang, Y., Oliver, B. G. G., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1435873 · Cited by 4
Coronavirus disease 2019 and pediatric anesthesia
Tan, J. M., Disma, N. M., & Matava, C. T. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001000 · Cited by 2
Diagnostic Applications for RNA-Seq Technology and Transcriptome Analyses in Human Diseases Caused by RNA Viruses
Louis, I. V.-S., Gorzalski, A., & Pandori, M. (2021) · Applications of RNA-Seq in Biology and Medicine [Working Title] · doi:10.5772/intechopen.99156 · Cited by 3
Improving ISOMAP Efficiency with RKS: A Comparative Study with t-Distributed Stochastic Neighbor Embedding on Protein Sequences
Ali, S., & Patterson, M. (2023) · J — Multidisciplinary Scientific Journal · doi:10.3390/j6040038 · Cited by 2
Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China
Bi, D., Luo, X., Chen, Z., Xie, Z., Zang, N., Mo, L., Liu, Z., Lin, Y., Qin, Y., Tang, X., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23029 · Cited by 2
Status of COVID-19 Pandemic Before the Administration of Vaccine
Thomas, S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_4 · Cited by 2
SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint
Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v5 · Cited by 2
Genomic Surveillance of SARS-CoV-2 in Erie County, New YorkPreprint
Lamb, N. A., Bard, J., Pohlman, A., Boccolucci, A., Yergeau, D. A., Marzullo, B. J., Pope, C., Burstein, G. R., Tomaszewski, J., Nowak, N. J., et al. (2021) · medRxiv · doi:10.1101/2021.07.01.21259869 · Cited by 2
Immunity Escape of SARS-CoV-2 Variants: Omicron Leads the WayPreprint
Dhingra, R., Sharma, A., Balda, S., Billa, A., Sah, S. N., Capalash, N., & Sharma, P. (2022) · Preprints.org · doi:10.20944/preprints202203.0376.v1 · Cited by 1
SARS-CoV2 Variants and Vaccines mRNA Spikes Fibonacci Numerical UA/CG MetastructuresPreprint
Perez, J. C. (2021) · Preprints.org · doi:10.20944/preprints202104.0034.v4 · Cited by 2
Lessons from COVID-19
Lele, U., & Goswami, S. (2024) · Medical Research Archives · doi:10.18103/mra.v12i2.5039 · Cited by 1
Molecular Epidemiology of SARS-CoV-2 Variants in Vaccinated and Non-Vaccinated Patients of Erbil Province, Kurdistan Region-Iraq
Hassan, D. A., Maulud, S. Q., Rashid, R. F., Ahmed, J. Q., & Ali, R. K. (2024) · BioMed Target Journal · doi:10.59786/bmtj.213 · Cited by 1
Detection of SARS-CoV-2 Delta Variant of Concern AY.57 and Clinical Characteristics of Imported Cases on a Vietnamese Coal Carrier Vessel in East Kalimantan, Indonesia: A Case Report
Marwan, M., Winardi, W., Mu'ti, A., Wahyuni, S., Jatmiko, R. W., Alfian, D. I., Nur, M. I., & Sewu, S. (2022) · Jurnal Respirasi · doi:10.20473/jr.v8-i.2.2022.99-105 · Cited by 1
Ethical Issues in Animal Cell Culture
Jindal, D., Vaishanavi, & Singh, M. (2023) · Techniques in life science and biomedicine for the non-expert · doi:10.1007/978-3-031-19485-6_20 · Cited by 1
Optimized workplace risk mitigation measures for SARS-CoV-2 in 2022
Pettit, R. W., Peng, B., Yu, P. L., Matos, P. G., Greninger, A. L., McCashin, J., & Amos, C. I. (2023) · Scientific Reports · doi:10.1038/s41598-023-29087-w · Cited by 1
Deep learning for discriminating non-trivial conformational changes in molecular dynamics simulations of SARS-CoV-2 spike-ACE2
dos Santos, L. M., de Mendonça, J. G., Lobo, Y. J. G., de Lima, L. H. F., Rocha, G. B., & de Melo-Minardi, R. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-72842-w · Cited by 2

Authors: Zhang, W., Davis, B. D., Chen, S. S., Sincuir Martinez, J. M., Plummer, J. T., & Vail, E.
Affiliations: Cedars-Sinai Medical Center (US)
Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California
Corresponding author: Plummer, Jasmine T.
ORCID: Zhang, Wenjuan
Davis, Brian D.
Plummer, Jasmine T.
Vail, Eric
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2021-04-06
Volume: 325
Issue: 13
Pages: 1324
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2021.1612
PMC: PMC7879386
OpenAlex: W3127156551
Cited by: 371
References: 10
Citations by year: 2026: 2 · 2025: 7 · 2024: 19 · 2023: 21 · 2022: 86 · 2021: 232
FWCI: 28.34
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
Locations: JAMA (publishedVersion, other-oa)
medRxiv (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords: SARS-CoV-2, COVID-19 pandemic, novel variants, viral variant emergence, phylogenetic analysis, viral genome sequencing, symptomatic patients, Southern California
MeSH terms: COVID-19, SARS-CoV-2, California, Humans, Mutation, Sequence Analysis, RNA, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks